Dr Mark Crabtree is Head of the Clinical Sciences Discipline and Senior Lecturer in Cardiovascular Biochemistry in the School of Biosciences within the Faculty of Health and Medical Sciences at the University of Surrey. He completed his BSc at the University of Surrey and earned his PhD at Weill Medical College of Cornell University in New York, USA, under Professor Steven Gross. In 2006, he began a postdoctoral position with Professor Keith Channon in the Division of Cardiovascular Medicine at the University of Oxford, where he later held an Oxford Centre of Research Excellence Fellowship from 2012 to 2014 and a British Heart Foundation Intermediate Fellowship from 2015 to 2021. He returned to the University of Surrey as a Senior Lecturer in 2022.
Dr Crabtree’s research focuses on the mechanisms of nitric oxide and redox signalling in molecular models of cardiovascular disease. He has published over 60 original articles in leading journals, with his work cited more than 3,000 times. He serves on the Editorial Board of the British Journal of Pharmacology and regularly reviews for journals including Free Radical Biology and Medicine, Nitric Oxide, Cardiovascular Research, Arteriosclerosis, Thrombosis, and Vascular Biology, and Circulation Research. He is an active council member of the Nitric Oxide Society and chaired the International Nitric Oxide Conference in Oxford in 2018.